Rong Zhou is SENIOR EVP, PRODUCTION CENTER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 118,469 shares of AMPH, which is worth approximately $4.13 Million. The most recent transaction as insider was on Jun 08, 2021, when has been sold 8,180 shares (Common Stock) at a price of $14.23 per share, resulting in proceeds of $116,401. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0.07% 3M change
5.38% 12M change
Total Value Held $4.13 Million

Rong Zhou Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2021
BUY
Exercise of conversion of derivative security
$116,401 $14.23 p/Share
8,180 Added 7.62%
99,156 Common Stock
May 14 2021
SELL
Open market or private sale
$343,503 $19.72 p/Share
17,419 Reduced 16.22%
89,966 Common Stock
May 14 2021
BUY
Exercise of conversion of derivative security
$158,238 $14.23 p/Share
11,120 Added 9.38%
107,385 Common Stock
May 13 2021
SELL
Open market or private sale
$13,706 $19.58 p/Share
700 Reduced 0.72%
96,265 Common Stock
May 13 2021
BUY
Exercise of conversion of derivative security
$9,961 $14.23 p/Share
700 Added 0.72%
96,965 Common Stock
Mar 17 2021
BUY
Grant, award, or other acquisition
-
21,984 Added 18.59%
96,265 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$60,907 $18.44 p/Share
3,303 Reduced 4.26%
74,281 Common Stock
Mar 15 2021
SELL
Payment of exercise price or tax liability
$31,636 $19.15 p/Share
1,652 Reduced 2.08%
77,584 Common Stock
RZ

Rong Zhou

SENIOR EVP, PRODUCTION CENTER
Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH